Literature DB >> 2149983

Down syndrome: toward a molecular definition of the phenotype.

J R Korenberg1, H Kawashima, S M Pulst, L Allen, E Magenis, C J Epstein.   

Abstract

Down syndrome (DS) is a major cause of mental retardation and heart disease. Although it is usually caused by the presence of an extra chromosome 21, a subset of the diagnostic features may be caused by the presence of only band q22. Molecular and cytogenetic analysis of a family with 4 DS members has significantly narrowed the chromosomal region responsible for the DS phenotype: congenital heart disease, facial features, and possibly dermatoglyphics. Using high-resolution chromosome banding and in situ hybridization, we found the DS phenotype in the family is caused by a duplication of chromosome 21 material including a region of distal band q22.1 below the limit of cytogenetic resolution, in addition to bands q22.2-q22.3. By quantitative Southern blot analyses of DS members of the family, all random DNA sequences and expressed genes mapping in band q22.1 and proximal are found not to be duplicated. These include cDNA probes for the genes for superoxide dismutase (SOD1) mapping in 21q22.1 and for the amyloid precursor protein (APP) mapping in 21q21.05; D21S46 in 21q11.2-21.05; and D21S47 and SF57 in 21q22.1-q22.3. With one exception, DNA sequences mapping in band q22.3 are duplicated (D21S39, D21SD42, and D21S43). This analysis has now been extended to show that D21S17, previously mapped to band 21q22.3, is not duplicated. In conclusion, the genes SOD1 and APP have been excluded from a necessary role in generating the classical DS features, and the proximal border of the chromosomal region causing DS has been defined.

Entities:  

Mesh:

Year:  1990        PMID: 2149983     DOI: 10.1002/ajmg.1320370719

Source DB:  PubMed          Journal:  Am J Med Genet Suppl        ISSN: 1040-3787


  8 in total

1.  Effects of overexpression of the liver subunit of 6-phosphofructo-1-kinase on the metabolism of a cultured mammalian cell line.

Authors:  A M Urbano; H Gillham; Y Groner; K M Brindle
Journal:  Biochem J       Date:  2000-12-15       Impact factor: 3.857

2.  Abnormal expression of the G-protein-activated inwardly rectifying potassium channel 2 (GIRK2) in hippocampus, frontal cortex, and substantia nigra of Ts65Dn mouse: a model of Down syndrome.

Authors:  Chie Harashima; David M Jacobowitz; Jassir Witta; Rosemary C Borke; Tyler K Best; Richard J Siarey; Zygmunt Galdzicki
Journal:  J Comp Neurol       Date:  2006-02-10       Impact factor: 3.215

3.  CSAX: Characterizing Systematic Anomalies in eXpression Data.

Authors:  Keith Noto; Saeed Majidi; Andrea G Edlow; Heather C Wick; Diana W Bianchi; Donna K Slonim
Journal:  J Comput Biol       Date:  2015-02-04       Impact factor: 1.479

4.  The genetic architecture of Down syndrome phenotypes revealed by high-resolution analysis of human segmental trisomies.

Authors:  Jan O Korbel; Tal Tirosh-Wagner; Alexander Eckehart Urban; Xiao-Ning Chen; Maya Kasowski; Li Dai; Fabian Grubert; Chandra Erdman; Michael C Gao; Ken Lange; Eric M Sobel; Gillian M Barlow; Arthur S Aylsworth; Nancy J Carpenter; Robin Dawn Clark; Monika Y Cohen; Eric Doran; Tzipora Falik-Zaccai; Susan O Lewin; Ira T Lott; Barbara C McGillivray; John B Moeschler; Mark J Pettenati; Siegfried M Pueschel; Kathleen W Rao; Lisa G Shaffer; Mordechai Shohat; Alexander J Van Riper; Dorothy Warburton; Sherman Weissman; Mark B Gerstein; Michael Snyder; Julie R Korenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2009-07-13       Impact factor: 11.205

Review 5.  Trisomy 21 and the brain.

Authors:  Robert E Mrak; W Sue T Griffin
Journal:  J Neuropathol Exp Neurol       Date:  2004-07       Impact factor: 3.685

6.  Olig1 and Olig2 triplication causes developmental brain defects in Down syndrome.

Authors:  Lina Chakrabarti; Tyler K Best; Nathan P Cramer; Rosalind S E Carney; John T R Isaac; Zygmunt Galdzicki; Tarik F Haydar
Journal:  Nat Neurosci       Date:  2010-07-18       Impact factor: 24.884

Review 7.  Theories of schizophrenia: a genetic-inflammatory-vascular synthesis.

Authors:  Daniel R Hanson; Irving I Gottesman
Journal:  BMC Med Genet       Date:  2005-02-11       Impact factor: 2.103

8.  Modeling Down Syndrome with Patient iPSCs Reveals Cellular and Migration Deficits of GABAergic Neurons.

Authors:  Hai-Qin Huo; Zhuang-Yin Qu; Fang Yuan; Lixiang Ma; Lin Yao; Min Xu; Yao Hu; Jing Ji; Anita Bhattacharyya; Su-Chun Zhang; Yan Liu
Journal:  Stem Cell Reports       Date:  2018-03-08       Impact factor: 7.765

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.